Phase I Study of LB-100 With Docetaxel in Solid Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by Lixte Biotechnology Holdings, Inc.
Sponsor:
Information provided by (Responsible Party):
Lixte Biotechnology Holdings, Inc.
ClinicalTrials.gov Identifier:
NCT01837667
First received: April 18, 2013
Last updated: December 12, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)